A blood test that could detect cancers early will undergo trials in the U.S.

  • 📰 IntEngineering
  • ⏱ Reading Time:
  • 98 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

Many companies developed blood tests for cancer, but none of them have FDA approval so far.

The U.S. is preparing to launch trials of blood tests that can improve the detection of multiple kinds of cancer,

by MIT Technology Review. The trial, which will be conducted by the National Cancer Institute, will test the efficacy of various blood tests in detecting cancer in 24,000 healthy participants over four years.The majority of the multi-cancer early detection tests function by searching for tumor cell remnants that explode after being attacked by the immune system. Debris from dead tumors can be found in the bloodstream, where it can be identified as a cancer warning before symptoms appear.

The only test that is currently used in the U.S. is the Galleri, which claims to detect more than 50 cancer types. However, it has some downsides, such as not having FDA approval. Therefore, it's not covered by most insurance and costs $949.According to new data shared by the test's developers, in a group of around 6,600 people who were believed to be healthy, the test discovered 35 cases of cancer, 26 of which were cancers not regularly checked for.the organ where the cancer is in.

False positives are also a problem for cancer screening, which is intended to involve sorting through a large number of healthy tests in order to detect cancer. Another danger is rushing. Even while some tumors never spread or become life-threatening, early discovery may prompt harsh treatment options like chemotherapy.results for cancer. Since companies flood the market with new tests, the NIC trial should provide a standard approach to launching cancer screening research.

"I don't think most companies tend to want to compare their tests head to head," says Timothy Rebbeck, a professor of cancer prevention at Harvard. "It's expensive and difficult. So somebody else, a neutral party like the NCI, needs to.", liver, and ovarian cancer, which are fatal and do not have any other screening options. "It seems very realistic to me to think that we could reduce death by half," he concludes.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

So what

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 287. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

“Liquid Biopsy” – Cost-Effective Early-Cancer Detection From Cell-Free DNA in Blood SamplesResearch led by UCLA’s Jonsson Comprehensive Cancer Center tests a cost-effective approach to early-cancer detection from cell-free DNA in blood samples. Early detection remains paramount to successfully treating many cancers. A growing research focal point is early detection via cell-free DNA (c
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

Alzheimer's-slowing drug labelled historicThe drug appears to reduce the pace of the disease, in early data from clinical trials. Don't give it to anti-vaxxers they know best.. I forgot to take mine. My dad has been diagnosed with Alzheimer since 2015, my mum found out about Sacha inchi’s oil slowing down Alzheimer, so he began to take it since 2017, just now after contracting Covid 19 ppl start to notice his illness bcos his lack of oxigent levels went down to 65% with covid
Source: bbchealth - 🏆 143. / 63 Read more »

Chinese Investors Could Snap Up Cryptocurrencies as Yuan Slides, Hedge Fund SaysNovum Alpha's Patrick Tan says yuan's slide, coupled with the property market swoon, may spur demand for cryptocurrencies. By godbole17 godbole17 Check out, a new gem TT2EFINANCE currently on presale, we can get huge profits when it's launch. A project that allows you earn by viewing contents on tiktok. Presale is ongoing join fast.
Source: CoinDesk - 🏆 291. / 63 Read more »

Katie Couric Discloses Breast Cancer DiagnosisKatie Couric, the former Today host and CBS Evening News anchor, announced today that she was diagnosed with breast cancer in June, underwent surgery in July and began radiation treatments earlier … 💉
Source: DEADLINE - 🏆 109. / 63 Read more »

Katie Couric says she's been treated for breast cancerKatie Couric says she was diagnosed with breast cancer on the first day of summer, and since has undergone surgery and radiation treatment.
Source: wjxt4 - 🏆 246. / 63 Read more »